# FDA recall D-0230-2026

> **Novocol Pharmaceutical of Canada, Inc.** · Class II · drug recall initiated 2025-10-31.

## Product

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by  Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

## Reason for recall

Defective container: cracked/broken cartridges

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-0230-2026
- **Recalling firm:** Novocol Pharmaceutical of Canada, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-10-31
- **Report date:** 2025-12-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Cambridge, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0230-2026

## Citation

> AI Analytics. FDA recall D-0230-2026. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0230-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*